Search Results

Display Settings
Results per page: 10
Sort By: Relevance
Filter
  • 1-10 of  7,185 results for ""AVEO Pharmaceuticals Inc.""

Your Filters

Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
News

U.S. Clinical Trial: AVEO Pharmaceuticals, Inc. Listed a New Clinical Trial to Study Ficlatuzumab in Combination With Cetuximab in Participants With Recurrent or Metastatic (R/M) HPV Negative Head and Neck Squamous Cell Carcinoma (FIERCE-HN).

  • Source: Contify Life Science News. 2023.

Record details

Read More Add to Saved list
×
Book

AVEO Pharmaceuticals, Inc

  • Source: Gale Business Insights. Jan 01, 2022

Record details

Read More Add to Saved list
×
Transcript

Q2 2022 Aveo Pharmaceuticals Inc Earnings Call - Final.

  • Source: Fair Disclosure Wire. 2022.

Record details

Read More Add to Saved list
×
News

FORM 8-K: AVEO Pharmaceuticals, Inc. Files Current Report (Nov 07, 2022).

  • Source: Financial Law Reporter. 2022.

Record details

Read More Add to Saved list
×
News

FORM 8-K: AVEO Pharmaceuticals, Inc. Files Current Report (Jan 05, 2023).

  • Source: Financial Law Reporter. 2023.

Record details

Read More Add to Saved list
×
News

FORM 8-K: AVEO Pharmaceuticals, Inc. Files Current Report (Jan 18, 2023).

  • Source: Financial Law Reporter. 2023.

Record details

Read More Add to Saved list
×
News

8-K: AVEO PHARMACEUTICALS, INC.

  • Source: EDGAR Online-8-K Glimpse. 2023.

Record details

Read More Add to Saved list
×
News

FORM 8-K: AVEO Pharmaceuticals, Inc. Files Current Report (Updated on AUG 04, 2022).

  • Source: Financial Law Reporter. 2022.

Record details

Read More Add to Saved list
×
News

FORM 8-K: AVEO Pharmaceuticals, Inc. Files Current Report (Dec 02, 2022).

  • Source: Financial Law Reporter. 2022.

Record details

Read More Add to Saved list
×
News

8-K: AVEO PHARMACEUTICALS, INC.

  • Source: EDGAR Online-8-K Glimpse. 2022.

Record details

Read More Add to Saved list
×
  • 1-10 of  7,185 results for ""AVEO Pharmaceuticals Inc.""